Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

Viad Shares Maintain Upward Trajectory on Strong Performance

Felix Baarz by Felix Baarz
November 27, 2025
in Earnings, MDAX & SDAX, Value & Growth
0
Viad Stock
0
SHARES
24
VIEWS
Share on FacebookShare on Twitter

Viad continues its impressive market run, propelled by outstanding quarterly results and a significant upward revision of its 2025 financial guidance. The company’s strategic pivot toward becoming a focused attractions provider appears to be yielding substantial benefits, with recent figures indicating both accelerated growth and enhanced profitability.

Strategic Shift and Financial Performance

The company’s transformation gained significant momentum with the announced sale of its GES business unit to Truelink Capital for $535 million. This transaction, expected to finalize by the end of 2024, will reposition Viad as a pure-play attractions and hospitality enterprise. The planned rebranding to Pursuit further emphasizes this strategic refocusing on the high-growth experiential travel sector.

This strategic clarity, combined with a strengthened balance sheet, provides a solid foundation for accelerated expansion. The company’s refreshed “Refresh, Build, Buy” strategy is being executed from a position of financial strength, with robust liquidity of $274.4 million and a moderate debt level.

Record-Breaking Third Quarter

Viad’s third-quarter 2025 financial results demonstrated remarkable strength across key metrics. Revenue surged by 32.2 percent to reach $241.0 million. Even more impressive was the performance in adjusted EBITDA, which climbed 41.5 percent to $117.4 million. The company reported net income of $73.9 million, with adjusted net income coming in at $75.3 million.

These results not only represent an acceleration of the company’s growth trajectory but also highlight substantially improved profit margins compared to previous periods.

Should investors sell immediately? Or is it worth buying Viad?

Revised Outlook Signals Confidence

Bolstered by this strong operational performance, management has raised its full-year 2025 adjusted EBITDA forecast. The company now anticipates adjusted EBITDA between $116 million and $122 million, representing a $6 million increase from the previous guidance range of $108 million to $118 million.

Key aspects of the updated outlook include:
* Projected growth of $39 to $45 million compared to 2024 results
* Expected revenue increase of approximately 24 percent for the full year 2025
* The revised guidance signals strong management confidence in continued operational excellence

Funding Future Expansion

Viad is supporting its ambitious growth targets with strategic capital investments. The company has allocated $124 million for acquisitions in 2025, including $111 million for the Tabacón Thermal Resort & Spa in Costa Rica. These purchases are expanding Viad’s global footprint in unique hospitality destinations.

Additional investment highlights include:
* Growth investments between $38 million and $43 million planned for 2025
* Over $250 million in organic investments scheduled through 2030
* Solid financial foundation enabling continued strategic execution

The combination of record financial performance, strategic focus, and disciplined investment continues to drive shareholder value, positioning Viad for sustained growth in the experiential travel market.

Ad

Viad Stock: Buy or Sell?! New Viad Analysis from March 25 delivers the answer:

The latest Viad figures speak for themselves: Urgent action needed for Viad investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Viad: Buy or sell? Read more here...

Tags: Viad
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock
Analysis

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Talphera Stock
Analysis

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Next Post
Grupo Supervielle Stock

Supervielle's Contradiction: Strong Growth Amid Argentina's Banking Crisis

Kraft Heinz Stock

Time is Running Out for Kraft Heinz Dividend Seekers

Coca-Cola Stock

Coca-Cola Considers Major Strategic Shift with Potential Costa Coffee Sale

Recommended

Finance_ People trading stocks

Analyst Upgrades QuinStreet Stock to Strong Buy with Increased Price Target

2 years ago
Trimble Stock

Trimble Stock: A Study in Contrasting Signals

7 months ago
Regency Centers Stock

Regency Centers Stock: Strong Dividend Hike Meets Market Skepticism

5 months ago
Cardinal Health Stock

Cardinal Health Shares Test Key Support Level Amid Sector Uncertainty

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Trending

Coherent Stock
AI & Quantum Computing

Coherent Stock Accelerates Toward New Highs on Key Breakthroughs

by Kennethcix
March 25, 2026
0

Shares of Coherent surged this week, propelled by a landmark technological demonstration and significant corporate developments that...

Corning Stock

Corning’s Strategic Alliance with Meta Fuels Investor Confidence

March 25, 2026
Dell Stock

Dell’s Quantum Security Push Amidst AI-Driven Growth

March 25, 2026
Gossamer Bio Stock

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Coherent Stock Accelerates Toward New Highs on Key Breakthroughs
  • Corning’s Strategic Alliance with Meta Fuels Investor Confidence
  • Dell’s Quantum Security Push Amidst AI-Driven Growth

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com